Comprehensive 2025 Point Of Care Hematology Diagnostics Market Overview: Trends, Forecasts, and Growth Drivers

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Point Of Care Hematology Diagnostics Market Through 2025?
In recent times, there has been a significant surge in the volume of the point of care hematology diagnostics market. It is projected to expand from $2.66 billion in 2024 to $2.90 billion in 2025, maintaining a compound annual growth rate (CAGR) of 9.1%. The accelerated growth in the past can be traced back to the escalating incidence rate of blood-related diseases, the growth of decentralized healthcare facilities, the heightened emphasis on early disease detection, the rise in healthcare spending in developing markets, and the augmented usage of portable diagnostic tools.

What's the Projected Size of the Global Point Of Care Hematology Diagnostics Market by 2029?
In the coming years, the market size for point of care hematology diagnostics is projected to experience robust expansion. The estimate for 2029 is to reach $4.05 billion, with a Compound Annual Growth Rate (CAGR) of 8.7%. This augmentation during the forecast period can be correlated with numerous factors such as the increased uptake of personalized medicine, escalating need for instantaneous clinical decisions, the surge in demand for home healthcare diagnostics, rising occurrence of blood-related disorders, and enhanced awareness regarding preventive healthcare. Major trends predicted for the forecast period encompass advanced connectivity capabilities in hematology analyzers, breakthroughs in sample preparation methods, incorporation of artificial intelligence in diagnostic equipment, innovation in single-cell analysis, integration of cloud-based data platforms, and progress in lab-on-a-chip solutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/point-of-care-hematology-diagnostics-global-market-report

Top Growth Drivers in the Point Of Care Hematology Diagnostics Industry: What's Accelerating the Market?
An increase in blood disorders is projected to fuel the expansion of the point-of-care hematology diagnostics market. Blood disorders encompass diseases impacting various components of blood and are mainly attributed to the growing prevalence of chronic diseases that directly affect the health of our blood, necessitating constant monitoring. Utilizing point-of-care hematology diagnostics allows for the expedited identification and observation of blood disorders by offering swift and precise results at or close to the patient's care location. This allows for faster medical decisions and better management of ailments. For example, the Perth Blood Institute, a non-profit organization based in Australia, reported that the number of hemophilia cases (a genetic disorder causing prolonged bleeding due to insufficient clotting factors in the blood) increased to 257,146 in 2022 from 233,577 in 2021. As such, the surging numbers of blood disorder cases are triggering the growth of the point-of-care hematology diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27388&type=smp

What Are the Key Trends Driving Point Of Care Hematology Diagnostics Market Growth?
Significant firms within the point-of-care hematology diagnostics marketplace are prioritizing the creation of technologically advanced offerings, including cartridge-based hematology analyzers that leverage artificial intelligence, aiming to provide quick, accurate, and on-site blood testing for enhanced patient care. Such cartridge-based AI-enabled hematology analyzers are modest diagnostic tools that employ single-use reagent cartridges and AI algorithms to swiftly and precisely evaluate blood samples on the spot. For example, Zoetis Inc., an American veterinary health company, unveiled Vetscan OptiCell in September 2024, an AI-powered, cartridge-based hematology analyzer engineered for veterinary applications. This cutting-edge system provides speedy results of full blood count (CBC) of reference laboratory quality within minutes at the point of care, along with reduced maintenance and manual interaction. It comes with sophisticated AI-based image assessment and viscoelastic focusing tech that perfectly positions cells for crystal clear imaging, facilitating accurate blood cell identification and automated anomaly detection, hence promoting effective and trustworthy veterinary diagnostic services.

What Are the Main Segments in the Point Of Care Hematology Diagnostics Market?
The point of care hematology diagnostics market covered in this report is segmented

1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types
2) By Product: Consumables, Systems
3) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product
4) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users

Subsegments:
1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)
2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level
3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin
4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation
5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27388&type=smp

Which Top Companies are Driving Growth in the Point Of Care Hematology Diagnostics Market?
Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., Medsource Ozone Biomedicals Pvt. Ltd., BioSystems S.A., Chengdu Seamaty Technology Co. Ltd., Drucker Diagnostics LLC, Diamond Diagnostics Inc., DIAGON Kft., BioMedomics Inc., Norma Instruments Zrt., PixCell Medical Technologies Ltd.

Which Regions Will Dominate the Point Of Care Hematology Diagnostics Market Through 2029?
North America was the largest region in the point of care hematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27388

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.